Literature DB >> 27317126

Benefits of L-alanine or L-arginine supplementation against adiposity and glucose intolerance in monosodium glutamate-induced obesity.

Thiago R Araujo1, Israelle N Freitas1, Jean F Vettorazzi2, Thiago M Batista2, Junia C Santos-Silva2, Maria L Bonfleur3, Sandra L Balbo3, Antonio C Boschero2, Everardo M Carneiro1, Rosane A Ribeiro4.   

Abstract

PURPOSE: L-alanine (Ala) and L-arginine (Arg) have been reported to regulate pancreatic β-cell physiology and to prevent body fat accumulation in diet-induced obesity. Here, we assessed growth and adiposity parameters, glucose tolerance, insulin secretion and the expression of insulin and nutrient-regulated proteins in monosodium glutamate (MSG)-obese mice supplemented with either Ala or Arg.
METHODS: Male newborn C57Bl/6 mice received a daily subcutaneous injection of MSG or saline solution (CTL group), during the first 6 days of life. From 30 to 90 days of age, MSG and CTL mice received or not 2.55 % Ala (CAla or MArg groups) or 1.51 % Arg-HCl (CArg or MArg groups) in their drinking water.
RESULTS: Adult MSG mice displayed higher adiposity associated with lower phosphorylation of the adipogenic enzyme, ACC, in adipose tissue. Glucose intolerance in MSG mice was linked to lower insulin secretion and to lower expression of IRβ in adipose tissue, as well as AS160 phosphorylation in skeletal muscle. Perigonadal fat depots were smaller in Ala and Arg mice, while retroperitoneal fat pads were decreased by Ala supplementation only. Both Ala and Arg improved fed-state glycemia as well as IRβ and pAS160 content, but only Ala led to improved glucose tolerance and insulin secretion. Adipostatic signals were increased in MAla mice, as indicated by enhanced AMPK phosphorylation and pACC content in fat depots.
CONCLUSIONS: Ala supplementation led to more pronounced metabolic improvements compared to Arg, possibly due to suppression of lipogenesis through activation of the AMPK/ACC pathway.

Entities:  

Keywords:  AMP-activated kinase; Insulin secretion; L-alanine supplementation; L-arginine supplementation; MSG obesity; Neuroendocrine disorder

Mesh:

Substances:

Year:  2016        PMID: 27317126     DOI: 10.1007/s00394-016-1245-6

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  44 in total

1.  Parasympathetic activity changes insulin response to glucose and neurotransmitters.

Authors:  S L Balbo; M L Bonfleur; E M Carneiro; M E C D Amaral; E Filiputti; P C F Mathias
Journal:  Diabetes Metab       Date:  2002-12       Impact factor: 6.041

2.  Insulin secretion and acetylcholinesterase activity in monosodium l-glutamate-induced obese mice.

Authors:  S Lucinei Balbo; C Gravena; M L Bonfleur; P C de Freitas Mathias
Journal:  Horm Res       Date:  2000

3.  The stimulus-secretion coupling of amino acid-induced insulin release. Insulinotropic action of L-alanine.

Authors:  Abdullah Sener; Willy J Malaisse
Journal:  Biochim Biophys Acta       Date:  2002-10-10

4.  Beneficial effects of L-arginine supplementation in experimental hyperlipemia-hyperglycemia in the hamster.

Authors:  Doina Popov; Gabriela Costache; Adriana Georgescu; Mirela Enache
Journal:  Cell Tissue Res       Date:  2002-03-02       Impact factor: 5.249

5.  Brain lesions in an infant rhesus monkey treated with monsodium glutamate.

Authors:  J W Olney; L G Sharpe
Journal:  Science       Date:  1969-10-17       Impact factor: 47.728

Review 6.  Arginine metabolism: nitric oxide and beyond.

Authors:  G Wu; S M Morris
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

7.  Dietary L-arginine supplementation reduces white fat gain and enhances skeletal muscle and brown fat masses in diet-induced obese rats.

Authors:  Wenjuan Jobgen; Cynthia J Meininger; Scott C Jobgen; Peng Li; Mi-Jeong Lee; Stephen B Smith; Thomas E Spencer; Susan K Fried; Guoyao Wu
Journal:  J Nutr       Date:  2008-12-23       Impact factor: 4.798

8.  Comparison of the obesity phenotypes related to monosodium glutamate effect on arcuate nucleus and/or the high fat diet feeding in C57BL/6 and NMRI mice.

Authors:  R Matyšková; L Maletínská; J Maixnerová; Z Pirník; A Kiss; B Železná
Journal:  Physiol Res       Date:  2007-10-11       Impact factor: 1.881

Review 9.  Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates.

Authors:  Wenjuan Shi Jobgen; Susan K Fried; Wenjiang J Fu; Cynthia J Meininger; Guoyao Wu
Journal:  J Nutr Biochem       Date:  2006-01-09       Impact factor: 6.048

Review 10.  Pharmacotherapy for obesity.

Authors:  Jong Kil Joo; Kyu Sup Lee
Journal:  J Menopausal Med       Date:  2014-12-24
View more
  7 in total

1.  The Reproductive Toxicity of Monosodium Glutamate by Damaging GnRH Neurons Cannot Be Relieved Spontaneously Over Time.

Authors:  Cheng-Xiang Wang; Yue Zhang; Qing-Feng Li; Hong-Liang Sun; Hai-Ling Chong; Jian-Xi Jiang; Qing-Chun Li
Journal:  Drug Des Devel Ther       Date:  2021-08-12       Impact factor: 4.162

2.  The Microbiota and It's Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease.

Authors:  Congwei Gu; Zihan Zhou; Zehui Yu; Manli He; Lvqin He; Zhengzhong Luo; Wudian Xiao; Qian Yang; Fangfang Zhao; Weiyao Li; Liuhong Shen; Jianhong Han; Suizhong Cao; Zhicai Zuo; Junliang Deng; Qigui Yan; Zhihua Ren; Mingde Zhao; Shumin Yu
Journal:  Front Cell Infect Microbiol       Date:  2022-05-27       Impact factor: 6.073

3.  The protective effect of Nigella sativa seeds against monosodium glutamate-induced hepatic dysfunction in rats.

Authors:  Mahmoud Abd-Elkareem; Mahmoud Soliman; Mokhless A M Abd El-Rahman; Nasser S Abou Khalil
Journal:  Toxicol Rep       Date:  2022-01-28

4.  Dietary L-arginine supplementation of tilapia (Oreochromis niloticus) alters the microbial population and activates intestinal fatty acid oxidation.

Authors:  Senlin Li; Chao Wang; Zhenlong Wu
Journal:  Amino Acids       Date:  2021-07-02       Impact factor: 3.520

5.  Extensive use of monosodium glutamate: A threat to public health?

Authors:  Kamal Niaz; Elizabeta Zaplatic; Jonathan Spoor
Journal:  EXCLI J       Date:  2018-03-19       Impact factor: 4.068

6.  Decreased diabetes risk over 9 year after 18-month oral L-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of L-arginine study).

Authors:  Lucilla D Monti; Elena Galluccio; Valentina Villa; Barbara Fontana; Serena Spadoni; Pier Marco Piatti
Journal:  Eur J Nutr       Date:  2017-10-20       Impact factor: 5.614

7.  Effect of Low-Fat Diet in Obese Mice Lacking Toll-like Receptors.

Authors:  Cheng-Shyuan Rau; Shao-Chun Wu; Tsu-Hsiang Lu; Yi-Chan Wu; Chia-Jung Wu; Peng-Chen Chien; Pao-Jen Kuo; Chia-Wei Lin; Chia-Wen Tsai; Ching-Hua Hsieh
Journal:  Nutrients       Date:  2018-10-09       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.